Filing Details
- Accession Number:
- 0001104659-23-037023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-27 13:12:20
- Reporting Period:
- 2023-03-23
- Accepted Time:
- 2023-03-27 13:12:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1689548 | Praxis Precision Medicines Inc. | PRAX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1707657 | Marcio Souza | C/O Praxis Precision Medicines, Inc. 99 High Street, 30Th Floor Boston MA 02110 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-23 | 35,000 | $0.86 | 226,299 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-03-23 | 35,002 | $0.86 | 35,002 | No | 4 | P | Indirect | Held by spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | Held by spouse |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.86 to $0.863, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8572 to $0.8676, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.